Ipamorelin 5mg

Ipamorelin is a synthetic pentapeptide classified as a selective growth-hormone secretagogue that acts as an agonist at the ghrelin receptor, also called the growth-hormone secretagogue receptor (GHS-R). It carries CAS number 170851-70-4 and a molecular weight of 711.86. In research it is noted for its selectivity, with studies reporting minimal effect on cortisol and prolactin relative to some other secretagogues examined in the same models.

Mechanistically, ipamorelin binds the GHS-R and, in experimental models, is reported to stimulate growth-hormone release from pituitary cells in a manner described as pulsatile and selective. Studies emphasise that this receptor targeting appears not to meaningfully raise cortisol, prolactin or other pituitary hormones in the systems examined, which is why ipamorelin is often characterised as a comparatively clean secretagogue throughout the research literature.

Within growth-hormone and endocrine research, ipamorelin is studied for its receptor selectivity and its reported effect on growth-hormone secretion profiles in laboratory and animal models. It is frequently investigated alongside CJC-1295 No-DAC, a GHRH analogue, in studies examining complementary secretagogue mechanisms. Laboratories sourcing Ipamorelin UK stock commonly reference this literature when designing controlled endocrine experiments and characterising secretagogue behaviour under defined conditions.

Sova Peptides supplies ipamorelin as a lyophilised research material for in-vitro and laboratory study by qualified researchers. Each batch is characterised by reverse-phase HPLC and ESI mass spectrometry, with a batch-linked Certificate of Analysis available to confirm identity and molecular weight. Standard lyophilised-peptide storage and handling apply throughout. This product is supplied strictly for laboratory research use only and is not for human or veterinary use.